CHU de Bordeaux, Groupe hospitalier Sud, Hôpital Haut-L'évêque

Pessac 33604

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure NYHA Class III and Ambulatory IV, Systemic Lupus Erythematosus

Studies at this site

• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed